This article directly stems from the research process for our global venture capital investors database. Based on this list and our advanced keyword crawler technology, we created a list of venture capital investors that mention biotech investment keywords on their website. The list – offered as an Excel file – is perfectly suited to get in touch with the most relevant investors in the field.
The biotech and life science sector has developed various advanced treatments, medicines, and diagnostics, especially, regarding patients suffering from cancer, age-related dieseases, skin conditions, and metabolic diseases. This article highlights three venture capital investors in the life science sector in Europe, based on the keyword crawler generated biotech and life science investor list.
1. Seventure Partners (France)
Seventure Partners, founded in 1997, had 850 € million net commitments under management in 2020. The company invests in businesses with strong growth potential from early to late stages in the digital technology and life science sector. Seventure Partners backs companies like Anaeropharma Science, a Japanese company focusing on the development of new treatments using core platform technology and Citryll, a business from the Netherlands that research pharmaceuticals and antibody therapeutics.
2. KIZOO Technology Capital GmbH (Germany)
KIZOO is a company that funds early-stage and follow-on projects that focus on rejuvenation biotech. Especially, research regarding the root causes of aging and certain therapies and services. Due to the extensive experience of the company founders they also offer mentorships and expertise in entrepreneurship and venture capital investment. The newest company added to their portfolio is MoglingBio, who develop new pharmacological therapies to rejuvenate old stem cells. Another interesting company in their portfolio is Cyclarity Therapeutics, that targets age-related conditions like heart-attacks and strokes with medication to combat arterial plaque build up.
3. EIR Ventures (Sweden)
Eir Ventures focuses on investments in private life science companies in the Nordic area. The company is supported by local and international investors as well as by Nordic universities. Eir Ventures is looking to improve healthcare systems, patient outcomes and society. They work closely with their portfolio companies, such as Henlez, who use enzymes to improve skin conditions or Synklino. Synklino’s mission for example is to develop a new treatment to decrease virus infections in transplant patients.
Picture Source: Hal Gatewood